EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 25.39 Billion EUR | 3.68% |
| 2022 | 24.49 Billion EUR | 23.58% |
| 2021 | 19.82 Billion EUR | 37.36% |
| 2020 | 14.42 Billion EUR | -17.03% |
| 2019 | 17.39 Billion EUR | 61.03% |
| 2018 | 10.8 Billion EUR | 44.19% |
| 2017 | 7.49 Billion EUR | 5.27% |
| 2016 | 7.11 Billion EUR | 5.94% |
| 2015 | 6.71 Billion EUR | 18.45% |
| 2014 | 5.67 Billion EUR | 11.94% |
| 2013 | 5.06 Billion EUR | 1.52% |
| 2012 | 4.98 Billion EUR | 19.08% |
| 2011 | 4.18 Billion EUR | 7.66% |
| 2010 | 3.89 Billion EUR | 19.08% |
| 2009 | 3.26 Billion EUR | 6.3% |
| 2008 | 3.07 Billion EUR | 5.72% |
| 2007 | 2.9 Billion EUR | 8.11% |
| 2006 | 2.68 Billion EUR | 10.96% |
| 2005 | 2.42 Billion EUR | 7.25% |
| 2004 | 2.26 Billion EUR | 6.8% |
| 2003 | 2.11 Billion EUR | -1.02% |
| 2002 | 2.13 Billion EUR | 3.28% |
| 2001 | 2.07 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.64 Billion EUR | 0.0% |
| 2024 Q1 | 6.64 Billion EUR | -47.03% |
| 2023 Q4 | 12.54 Billion EUR | 100.0% |
| 2023 FY | 25.39 Billion EUR | 3.68% |
| 2023 Q1 | 6.42 Billion EUR | -48.6% |
| 2023 Q2 | 12.85 Billion EUR | 100.0% |
| 2023 Q3 | 6.27 Billion EUR | -51.19% |
| 2022 Q2 | 11.99 Billion EUR | 100.0% |
| 2022 FY | 24.49 Billion EUR | 23.58% |
| 2022 Q1 | 5.99 Billion EUR | -45.74% |
| 2022 Q3 | 6.25 Billion EUR | -47.89% |
| 2022 Q4 | 12.5 Billion EUR | 100.0% |
| 2021 Q3 | 5.52 Billion EUR | -36.98% |
| 2021 FY | 19.82 Billion EUR | 37.36% |
| 2021 Q1 | 4.38 Billion EUR | -46.53% |
| 2021 Q2 | 8.76 Billion EUR | 100.0% |
| 2021 Q4 | 11.05 Billion EUR | 100.0% |
| 2020 FY | 14.42 Billion EUR | -17.03% |
| 2020 Q1 | 3.11 Billion EUR | -63.84% |
| 2020 Q2 | 6.23 Billion EUR | 100.0% |
| 2020 Q3 | 4.09 Billion EUR | -34.2% |
| 2020 Q4 | 8.19 Billion EUR | 100.0% |
| 2019 Q3 | 4.3 Billion EUR | -50.92% |
| 2019 FY | 17.39 Billion EUR | 61.03% |
| 2019 Q2 | 8.77 Billion EUR | 100.0% |
| 2019 Q1 | 4.38 Billion EUR | 40.1% |
| 2019 Q4 | 8.61 Billion EUR | 100.0% |
| 2018 Q1 | 2.28 Billion EUR | -14.2% |
| 2018 Q3 | 3.13 Billion EUR | 37.1% |
| 2018 Q4 | 3.13 Billion EUR | 0.0% |
| 2018 FY | 10.8 Billion EUR | 44.19% |
| 2018 Q2 | 2.28 Billion EUR | 0.0% |
| 2017 Q3 | 2.66 Billion EUR | 37.99% |
| 2017 Q2 | 1.92 Billion EUR | 0.0% |
| 2017 Q1 | 1.92 Billion EUR | 9.26% |
| 2017 FY | 7.49 Billion EUR | 5.27% |
| 2017 Q4 | 2.66 Billion EUR | 0.0% |
| 2016 Q2 | 1.79 Billion EUR | 0.0% |
| 2016 FY | 7.11 Billion EUR | 5.94% |
| 2016 Q4 | 1.76 Billion EUR | 0.0% |
| 2016 Q3 | 1.76 Billion EUR | -1.42% |
| 2016 Q1 | 1.79 Billion EUR | 8.31% |
| 2015 Q4 | 1.65 Billion EUR | 0.0% |
| 2015 Q2 | 1.7 Billion EUR | 0.0% |
| 2015 Q1 | 1.7 Billion EUR | 17.92% |
| 2015 FY | 6.71 Billion EUR | 18.45% |
| 2015 Q3 | 1.65 Billion EUR | -2.93% |
| 2014 Q3 | 1.44 Billion EUR | 3.96% |
| 2014 FY | 5.67 Billion EUR | 11.94% |
| 2014 Q1 | 1.39 Billion EUR | 11.69% |
| 2014 Q4 | 1.44 Billion EUR | 0.0% |
| 2014 Q2 | 1.39 Billion EUR | 0.0% |
| 2013 Q1 | 1.28 Billion EUR | 0.0% |
| 2013 Q2 | 1.28 Billion EUR | 0.0% |
| 2013 Q3 | 1.24 Billion EUR | -3.38% |
| 2013 Q4 | 1.24 Billion EUR | 0.0% |
| 2013 FY | 5.06 Billion EUR | 1.52% |
| 2012 FY | 4.98 Billion EUR | 19.08% |
| 2011 FY | 4.18 Billion EUR | 7.66% |
| 2010 FY | 3.89 Billion EUR | 19.08% |
| 2009 FY | 3.26 Billion EUR | 6.3% |
| 2008 FY | 3.07 Billion EUR | 5.72% |
| 2007 FY | 2.9 Billion EUR | 8.11% |
| 2006 FY | 2.68 Billion EUR | 10.96% |
| 2005 FY | 2.42 Billion EUR | 7.25% |
| 2004 FY | 2.26 Billion EUR | 6.8% |
| 2003 FY | 2.11 Billion EUR | -1.02% |
| 2002 FY | 2.13 Billion EUR | 3.28% |
| 2001 FY | 2.07 Billion EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -795613.83% |
| Ansell Limited | 1.61 Billion USD | -1468.27% |
| Ansell Limited | 1.61 Billion USD | -1468.27% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -13653.234% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -18803350.446% |
| Psykey, Inc. | 419.29 Thousand USD | -6056437.22% |
| ConvaTec Group Plc | 2.19 Billion USD | -1057.467% |
| ConvaTec Group Plc | 2.14 Billion USD | -1085.353% |
| Encision Inc. | 6.58 Million USD | -385497.555% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -1391464.037% |
| LifePoint, Inc. | -18.5 Thousand USD | 137270370.27% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -372643.285% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -3289407.772% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -2574883.269% |
| Reflect Scientific, Inc. | 1.08 Million USD | -2350953.646% |
| SmileDirectClub, Inc. | 470.74 Million USD | -5294.663% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -1256.854% |
| SheerVision, Inc. | 3.49 Million USD | -725594.382% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -1831762.505% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -3408199.367% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -24351903.682% |